Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Dorzolamide hydrochloride and timolol maleate

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Dorzolamide Hydrochloride and Timolol Maleate is a prescription eye drop solution used to lower pressure inside the eye, often for treating glaucoma or ocular hypertension. It combines two medications: dorzolamide (a carbonic anhydrase inhibitor) and timolol (a beta-blocker) to reduce fluid production in the eye. Manufactured by Somerset Therapeutics, LLC, it's available as a 10 mL bottle. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov